Small Volume Blood Testing Validity and Acceptability for HIV-1 and Hepatitis B (TINIES for BBVs)
NCT05690607 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2023-01-19
Summary
During the Covid-19 pandemic era, patients indicated that they find a model of care incorporating remote consultations to be acceptable \[1-3\]. Remote accessibility to care can be enhanced by using new technology to allow small volume testing for routine blood samples. This study aims to prospectively validate the use of small volume blood sampling for routine HIV-1 and Hepatitis B Virus (HBV) viral load (VL), liver function tests (LFTs) and creatinine, and assess the acceptability of this method of blood sampling to people living with HIV (PLWH). These tests form the usual minimum required for safe monitoring on a routine basis to determine viral activity, liver and renal function in patients either on or off antiviral therapy. The UK based Doctors Laboratory TINIES small volume blood testing kits comprise microcontainers manufactured by BD Diagnostics designed for sample collection from skin puncture, along with home testing pack with lancets, instructions and Royal Mail postal packs. We will collect TINIES samples alongside routine venepuncture samples in people attending their routine clinic follow ups. We will then send kits to different participants to collect samples in their own home, along with a follow up questionnaire (written/online). Finally, we will conduct a more in-depth telephone interview for a subset of patients to qualitatively assess acceptability. Routine use of this method of testing could revolutionise care of people living with chronic blood borne viruses, for example HIV and chronic HBV. TINIES could enable remote monitoring, increasing ease of access to care, reducing clinic appointment burden in otherwise healthy individuals, and reduce labour costs in the NHS, for example, by reducing phlebotomy appointments.
Conditions
- HIV Infections
- Hepatitis B
Interventions
- OTHER
-
Doctors Laboratory TINIES small volume blood testing kit
Doctors Laboratory TINIES small volume blood testing kits comprise microcontainers manufactured by BD Diagnostics designed for sample collection from skin puncture, along with home testing pack with lancets, instructions and Royal Mail postal packs.
Sponsors & Collaborators
-
British HIV Association (BHIVA)
collaborator UNKNOWN -
Central and North West London NHS Foundation Trust
lead OTHER
Principal Investigators
-
Stuart Flanagan, MBBS · Central and North West London NHS Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-23
- Primary Completion
- 2023-09-30
- Completion
- 2024-01-22
More Related Trials
-
Study of Antiretroviral Therapy to Prevent HBV Intrauterine Infection
NCT02719808 ·Status: UNKNOWN
-
Effect of Entecavir Versus Tenofovir on HBV DNA Level in Peripheral Blood Mononuclear Cells
NCT05168293 ·Status: UNKNOWN
-
A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection
NCT01020565 ·Status: COMPLETED ·Phase: PHASE2
-
Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection
NCT01273142 ·Status: UNKNOWN
-
Hepatitis B Virus Vertical Transmission From HIV-HBV Co-infected Women
NCT02044068 ·Status: COMPLETED
-
Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B
NCT01743079 ·Status: COMPLETED ·Phase: PHASE4
-
Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy
NCT01037166 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV
NCT00051090 ·Status: WITHDRAWN ·Phase: NA
-
A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection
NCT07245953 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B
NCT01925820 ·Status: UNKNOWN ·Phase: PHASE4
-
Application of HBV Rapid Tests as a Tool for Wide-Use Screening
NCT01767597 ·Status: COMPLETED ·Phase: NA
-
Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Entecavir Plus Tenofovir
NCT03236610 ·Status: UNKNOWN ·Phase: PHASE3
-
Finite Versus Continuous Nucleos(t)Ide Analogues for Chronic Hepatitis B
NCT05793268 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Phase II Dose Response Study in Japan in Chronic Hepatitis B
NCT01022801 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection
NCT07183306 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients
NCT03962803 ·Status: UNKNOWN ·Phase: PHASE4
-
Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
NCT00524173 ·Status: TERMINATED ·Phase: PHASE2
-
Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B
NCT00410072 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B
NCT00117676 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B
NCT00646503 ·Status: COMPLETED ·Phase: PHASE4
-
Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies
NCT00142298 ·Status: COMPLETED ·Phase: PHASE3
-
TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction
NCT02338674 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection
NCT01037062 ·Status: COMPLETED ·Phase: PHASE2
-
Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B
NCT02069678 ·Status: COMPLETED
-
Use of TDF in Patients With Inactive Chronic Hepatitis B Infection
NCT02600117 ·Status: COMPLETED ·Phase: PHASE3